A team of researchers at Roswell Park Comprehensive Cancer Center, led by Dhyan Chandra, Ph.D., has discovered a new ...

Researchers conducted a retrospective study using data from 182 subjects with high-risk recurrent prostate cancers.

Apalutamide is under clinical development by Johnson & Johnson and currently in Phase II for Prostate Cancer. According to GlobalData, Phase II drugs for Prostate Cancer have a 23% phase transition ...

The findings show that more extensive research on how pesticides impact the development and severity of various cancers is ...

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

Discovery May Open New Way to Attack Prostate Cancer Dec. 3, 2024 — A special protein can play a key role in the fight against certain types of prostate cancer. Until now, treatments have ...

The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.

The AP reported that Netanyahu is expected to remain in the hospital for several days. According to Johns Hopkins Medicine, it is recommended not to perform strenuous activity or heavy lifting for at ...

King Charles III was diagnosed with cancer earlier this year after a hospital visit for an enlarged prostate. This is how treatment is going.